Articles by Jennifer Tsang, PhD

Gut microbes can protect or sensitize each other to drugs, even to non-antibiotics.

Nanobodies that bacteria secrete only in the presence of a biomarker treat inflammatory bowel disease at the site of inflammation.

Bacteria’s constant interaction with viruses has led them to evolve antiviral strategies.

Proteins from intracellular pathogens can help expel drugs delivered by macrophages.

A new metabolic model predicted short-chain fatty acid production based on an individual’s microbiome, diet, and prebiotic or probiotic input.

Researchers investigated the feasibility of microbiome-based drug delivery as a longer-lasting alternative to current topical formulations.

Fully synthetic approaches expand the repertoire of possible antimicrobials to overcome existing antibiotic resistance mechanisms.